Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-246P is a pseudogene of the U6 small nuclear RNA gene family, denoted as "RNA, U6 small nuclear 246, pseudogene". Pseudogenes are non-functional segments of DNA that resemble functional genes but lack their biological activity. The U6 small nuclear RNA (snRNA) itself is a highly conserved and crucial component of the spliceosome complex, critical for pre-mRNA splicing in eukaryotic cells[3][1]. However, RNU6-246P contains sequence similarities to the functional U6 snRNA, but due to its pseudogene status, it does not produce a functional RNA product and is regarded as a genomic relic with no recognized biochemical or disease-modifying function[2][5]. Pseudogenes like RNU6-246P commonly arise via retrotransposition mechanisms and serve as markers of genome evolution and retrotransposon dynamics, but they are not considered therapeutic targets, biomarkers, or active biological molecules in disease or drug response[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 246, pseudogene (RNU6-246P).